Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kite Pharma
AddedFeb 13, 2024
UpdatedJun 28, 2026
Kite Pharma

Kite Pharma

Acquired

Kite Pharma, Inc. pioneers in biomedical engineering, developing and manufacturing cancer immunotherapy products.

HQ
Santa Monica, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Kite Pharma, Inc., founded in 2009, is a biomedical engineering company with a core mission to develop innovative cancer immunotherapy products. The company's vision is to restore and enhance the patient's immune system to recognize and eradicate tumors effectively. Kite Pharma specializes in designing and manufacturing personalized cancer treatments, particularly focusing on chimeric antigen receptor (CAR) T-cell therapies. Their market focus is on providing advanced therapeutic solutions for patients with various types of cancer.

Notable figures associated with Kite Pharma include Arie Belldegrun, a renowned oncologist and the company's founder. The company has attracted significant investment from prominent venture capital firms and was acquired by Gilead Sciences in 2017 for $11.9 billion, highlighting its substantial impact and potential in the biopharmaceutical industry. Kite Pharma's key achievements include the FDA approval of Yescarta, a groundbreaking CAR T-cell therapy for certain types of lymphoma, marking a significant advancement in cancer treatment and solidifying its role as a leader in immunotherapy.

Kite Pharma - Similar Companies

Seagen logo

Seagen

seagen.com

Chimera Bioengineering logo

Chimera Bioengineering

chimera.bio

Clovis Oncology logo

Clovis Oncology

Nantkwest logo

Nantkwest

Blueprint Medicines logo

Blueprint Medicines

Immpact Bio logo

Immpact Bio

immpact-bio.com

Allogene Therapeutics logo

Allogene Therapeutics

allogene.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Immunome logo

Immunome

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Duet BioTherapeutics logo

Duet BioTherapeutics

PharmaCyte Biotech logo

PharmaCyte Biotech

pharmacyte.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Kestrel Therapeutics logo

Kestrel Therapeutics

Cel-Sci logo

Cel-Sci

cel-sci.com

Kite Pharma - Quick Facts

Who are Kite Pharma's competitors?

Companies similar to Kite Pharma include Seagen, Chimera Bioengineering, Clovis Oncology and Nantkwest.

When was Kite Pharma founded?

Kite Pharma was founded in 2009.

Where is Kite Pharma's headquarters located?

Kite Pharma's headquarters is located in Santa Monica, CA, US.

When was Kite Pharma's last funding round?

Kite Pharma's most recent funding round was for $250.1M (USD) in December 2015.

How much has Kite Pharma raised to-date?

As of Dec 10, 2015, Kite Pharma has raised a total of $335.4M (USD).

Kite Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research